La evolucion /

gan Crusafont Pairó, Miguel, Melendez, B., Aguirre, E.
Cyhoeddwyd 1966.

P04.18 PROGNOSIS IMPACT OF THE REGIONAL DISTRIBUTION OF MGMT GENE METHYLATION ACCORDING TO THE CPGISLAND METHYLATOR PHENOTYPE AND AGE IN HIGH-GRADE GLIOMAS

gan Mur, P., de Lope, A. Rodriguez, Hernandez-Iglesias, T., Diaz, F., Ribalta, T., Fiaño, C., Garcia, J.F., Rey, J.A., Mollejo, M., Meléndez, B.
Cyhoeddwyd 2014

P01.126 Frequent Tp53 and ATRX/DAXX gene alterations in giant cell IDH-Wildtype Glioblastomas

gan Cantero Montenegro, D, D’Haene, N, Rodríguez de Lope, Á, Sepulveda, J, de Neve, N, Fiaño, C, Gutiérrez-Guamán, M, Mollejo, M, Salmon, I, Hernandez-Laín, A, Melendez, B
Cyhoeddwyd yn Neuro Oncol (2018)

Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action

gan Lorente, M, Torres, S, Salazar, M, Carracedo, A, Hernández-Tiedra, S, Rodríguez-Fornés, F, García-Taboada, E, Meléndez, B, Mollejo, M, Campos-Martín, Y, Lakatosh, S A, Barcia, J, Guzmán, M, Velasco, G
Cyhoeddwyd 2011

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity

gan Park, J, Talukder, AH, Lim, SA, Kim, K, Pan, K, Melendez, B, Bradley, SD, Jackson, KR, Khalili, JS, Wang, J, Creasy, C, Pan, BF, Woodman, SE, Bernatchez, C, Hawke, D, Hwu, P, Lee, KM, Roszik, J, Lizée, G, Yee, C
Cyhoeddwyd yn Cancer Immunol Res (2017)